49 results on '"Gooderham, Melinda J."'
Search Results
2. Long-Term Multiple Center Experience in Treating Plaque Psoriasis With Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion
3. Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway
4. Reasons for the Termination of Interleukin-17 Inhibitor Medications in the Treatment of Plaque Psoriasis: A Real-World Retrospective Study
5. Practice Patterns Around the Management of Atopic Dermatitis in 2018 and 2020
6. Practice Patterns of Palmoplantar Pustulosis: Patient Demographics and Treatment Options
7. Real-World Moderate-to-Severe Hidradenitis Suppurativa: Decrease in Disease Burden With Adalimumab
8. Achenbach Syndrome (Paroxysmal Finger Hematoma)
9. Healthcare Providers Face Numerous Challenges in Treating Patients with Psoriasis: Results from a Mixed-Methods Study
10. Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort Study
11. Improvement of granulomatous skin conditions with tofacitinib in three patients: A case report
12. Return of Lymantria dispar dispar (gypsy moth): A case report
13. Topical PDE-4 Inhibitors are Emerging for Psoriasis Treatment
14. Uncommon Adverse Effects of Deoxycholic Acid Injection for Submental Fullness: Beyond the Clinical Trials
15. Long-Term Single Center Experience in Treating Plaque Psoriasis With Guselkumab
16. Management of Plaque Psoriasis With Biologic Therapies in Women of Child-Bearing Potential Consensus Paper
17. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review
18. Canadian Research Contributions per Medical Specialty in 2 High-Impact Journals
19. The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature
20. Acrodermatitis continua of Hallopeau successfully treated with adalimumab: A case report
21. Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document
22. Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section I: Pathophysiology of Atopic Dermatitis and Implications for Systemic Therapy
23. Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis
24. Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section III: Evaluation of Atopic Dermatitis Patients for Comorbidities
25. Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section V: Consensus Statements on the Assessment and Management of Adult Patients With Moderate-to-Severe Atopic Dermatitis
26. Eight-Patient Case Series of Palmoplantar Pustulosis Treated Successfully With Apremilast
27. Canadian Patients’ Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys
28. An Update on the Use of Alitretinoin for Chronic Hand Dermatitis in a Dermatology Practice Setting
29. Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections
30. A Guide to Topical Vehicle Formulations
31. Persistency of Biologic Therapies for Plaque Psoriasis in 2 Large Community Practices
32. Atopic Dermatitis, Depression, and Suicidality
33. Review of Atopic Dermatitis and Topical Therapies
34. Real-World Experience With Apremilast in Treating Psoriasis
35. Predictors of Topical Use in Psoriasis Patients in the REFINE Study
36. Real-World Experience with Alitretinoin in a Community Dermatology Practice Setting in Patients with Chronic Hand Dermatitis
37. Author's Reply
38. Concomitant Digoxin Toxicity and Warfarin Interaction in a Patient Receiving Clarithromycin
39. Sun and the Skin: Evaluation of a Sun Awareness Program for Elementary School Students
40. Impact of a Sun Awareness Curriculum on Medical Students' Knowledge, Attitudes, and Behaviour
41. Reasons for the Termination of Interleukin-17 Inhibitor Medications in the Treatment of Plaque Psoriasis: A Real-World Retrospective Study.
42. Clinical Implications of Targeting the JAK-STAT Pathway in Psoriatic Disease: Emphasis on the TYK2 Pathway.
43. Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort Study.
44. Topical PDE-4 Inhibitors are Emerging for Psoriasis Treatment.
45. A Guide to Topical Vehicle Formulations.
46. Persistency of Biologic Therapies for Plaque Psoriasis in 2 Large Community Practices.
47. Review of Atopic Dermatitis and Topical Therapies.
48. Real-World Experience With Apremilast in Treating Psoriasis.
49. Predictors of Topical Use in Psoriasis Patients in the REFINE Study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.